A new trading day began on Tuesday, with Revolution Medicines Inc (NASDAQ: RVMD) stock price down -1.58% from the previous day of trading, before settling in for the closing price of $39.77. RVMD’s price has ranged from $29.17 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -32.12%. With a float of $161.93 million, this company’s outstanding shares have now reached $186.26 million.
The extent of productivity of a business whose workforce counts for 534 workers is very important to gauge. In terms of profitability, gross margin is 45.12%, operating margin of -301.78%, and the pretax margin is -266.93%.
Revolution Medicines Inc (RVMD) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 13.07%, while institutional ownership is 93.67%. The most recent insider transaction that took place on Jun 16 ’25, was worth 86,923. Before that another transaction happened on Jun 16 ’25, when Company’s Officer proposed sale 3,732 for $40.79, making the entire transaction worth $152,228.
Revolution Medicines Inc (RVMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -32.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.42% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Here are Revolution Medicines Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00, a number that is poised to hit -1.15 in the next quarter and is forecasted to reach -5.08 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
The latest stats from [Revolution Medicines Inc, RVMD] show that its last 5-days average volume of 1.35 million was inferior to 1.63 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 32.00%. Additionally, its Average True Range was 1.65.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 64.28%, which indicates a significant increase from 37.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.11% in the past 14 days, which was lower than the 50.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.80, while its 200-day Moving Average is $43.46. Now, the first resistance to watch is $40.09. This is followed by the second major resistance level at $41.05. The third major resistance level sits at $41.52. If the price goes on to break the first support level at $38.66, it is likely to go to the next support level at $38.19. The third support level lies at $37.23 if the price breaches the second support level.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
With a market capitalization of 7.29 billion, the company has a total of 186,268K Shares Outstanding. Currently, annual sales are 0 K while annual income is -600,090 K. The company’s previous quarter sales were 0 K while its latest quarter income was -213,420 K.
